Metaxalone
Product Images NDC 61919-262

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metaxalone (NDC 61919-262). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct Rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Figure01)

A line graph showing mean (SD) concentrations of Metaxalone following an 800 mg dose under fasted and fed conditions. The y-axis represents concentration in ng/mL, ranging from 0 to 5000, and the x-axis shows time in hours from 0 to 12. Two curves are shown: one for fasted (open circles) and one for fed (filled circles) conditions, with the fed condition displaying higher concentration levels over time.*

FDA Label Image

Image Description (Label)

Packaging label for METAXALONE 800 mg tablets by Direct RX, containing 30 tablets per bottle. The label indicates the product is generic for Skelaxin and each tablet contains 800 mg of Metaxalone. It includes lot, production number, discard date, and packaging information. Warnings about drowsiness or dizziness are also present.*

FDA Label Image

Image Description (Structure)

Chemical structure of Metaxalone showing a benzene ring with two methyl groups, an ether linkage, and a morpholine ring with a carbonyl group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.